News
9h
Inquirer.net on MSNPhilHealth coverage for both kidney transplant patients, organ donorsThe Health Insurance Corp. (PhilHealth) will now shoulder the cost of medications and tests for end-stage or stage 5 chronic ...
An investigational drug developed by Eolo Pharma is showing promise in animal experiments and an early human trial. It could ...
"Onco360 is grateful for the opportunity to partner with the team at Nuvation Bio and become a specialty pharmacy provider ...
Explore the science of creatine's effects on muscle growth and recovery. Discover how this go-to supplement can enhance your ...
3d
Money Talks News on MSNExperimental Pill Burns Fat Without Appetite Suppression in Early TrialNew obesity pill SANA burns fat without suppressing appetite, showing 3% weight loss in preliminary human trial through novel creatine pathway.
The latest clinical win follows a dual set of phase 3 and phase 2 results back in March. In that data drop, Mineralys reported that lorundrostat reduced systolic blood pressure in a late-stage study ...
Researchers at Yale School of Medicine have determined that a panel of biomarkers can help physicians better understand ...
6d
News-Medical.Net on MSNNew insights into gout management strategies and cardiovascular outcomesThe European Alliance of Associations for Rheumatology - recommends that serum urate should be maintained at <6 mg/dL ...
5d
MedPage Today on MSNFecal Transplant Noninferior to Vancomycin for Initial C. Diff TherapyFecal microbiota transplant was noninferior to vancomycin as the initial treatment for C. diff in a randomized, open-label trial. Transplant showed slightly higher cure rates without recurrence and ...
U.S. FDA Drug Safety Alert: Warning Issued for Severe Itching After Stopping Long-Term Cetirizine or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results